Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Interactive Tools
Sponsored
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Management of Drug-Induced Interstitial Lung Disease
EP. 1: Antibody Drug Conjugates and Interstitial Lung Disease Risk
June 30th 2020
EP. 2: Risks for Developing ILD and Personal Experience
June 30th 2020
EP. 3: Changes in Cancer Treatment and Management of ILD
June 30th 2020
EP. 4: Use of Antibody Drug Conjugates and Potential for ILD
June 30th 2020
EP. 5: Rate and Class Effect of ILD with Antibody Drug Conjugates
June 30th 2020
EP. 6: CDK 4/6 Inhibitors and Identifying ILD in Patients
June 30th 2020
EP. 7: Managing Patient Symptoms and Clinician Education
June 30th 2020
EP. 8: Drug-Induced ILD and Rate of Occurrence in GI Cancer Trials
June 30th 2020
EP. 9: Patient Factors for Developing ILD and Personal Experience
June 30th 2020
EP. 10: Patient Management upon Developing ILD and Education
June 30th 2020
NEXT PAGE
<
1
2
3
>
PREVIOUS PAGE